Investor Summary

An investment in PhytoMyco offers compelling advantages:

• Expedited entry into the market (18 months): one of the anti-diabetic products under AYUSH regulatory compliances
• The company products address unmet medical needs for a large patient population
• The Company products are patent protected
• Experienced Management Team and Advisors to implement the strategy
• Large portfolio of future products for development
• PhytoMyco is open to business/marketing alliances

PhytoMyco is driving long-term value and sustainability by generating an internal pipeline of lead products which PhytoMyco will exclusively develop and co-develop with partners.